HPV16病毒衣壳抗体表位聚类分析与鼠单克隆抗体面板关系研究
本研究制备并表征了一组针对HPV16 L1的鼠单克隆抗体,通过交叉抑制和竞争实验将其分为五个表位组,并用国际标准血清05/134校准。研究发现识别不同表位的两种单克隆抗体在假病毒中和试验中表现出协同作用,这些中和抗体可用于开发表位特异性检测方法以监测疫苗生产和血清学评估。
要点
- HPV16 L1鼠单克隆抗体通过交叉抑制和竞争实验分为五个表位组。
- 两种识别不同表位的单克隆抗体在假病毒中和试验中显示协同作用。
- 国际标准血清05/134用于校准单克隆抗体和疫苗受者血清样本。
核心结论
- 针对HPV16 L1的鼠单克隆抗体可聚类为五个表位组,识别不同表位的两种抗体在假病毒中和试验中表现出协同作用。
研究设计与样本
- 研究制备了一组针对HPV16 L1的鼠单克隆抗体,并对其在病毒衣壳上的表位谱进行综合表征。
主要发现
- 通过基于成对交叉抑制和与人多克隆抗体竞争两种方法,将鼠单克隆抗体分为五个表位组。
- 使用充分表征的人单克隆抗体26D1进行交叉封闭实验,初步展示了这些鼠单克隆抗体识别表位的空间关系。
- 发现两种识别不同表位的单克隆抗体在假病毒中和试验中协同作用。
关键数值与推荐
- 使用国际标准血清05/134校准鼠单克隆抗体以及HPV16/18疫苗受者的人血清样本。
临床怎么用
- 中和单克隆抗体,特别是识别免疫优势表位的抗体,可用于开发表位特异性检测方法以监测疫苗生产过程。
- 这些抗体可用于血清学评估。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human papillomavirus (HPV) type 16 is the most common type implicated as the etiological agent that causes cervical cancer. The marketed prophylactic vaccines against HPV infection are composed of virus-like particles (VLPs) assembled from the recombinant major capsid protein L1. Elicitation of functional and neutralizing antibodies by vaccination is the mode of action by which the vaccines prevent the viral infection. In this study, a panel of murine mAbs against HPV16 L1 were generated and comprehensively characterized with respect to their mapping to the epitope spectrum on the viral capsid. These mAbs were categorized into five epitope bins by two different methods based on the pairwise cross-inhibition and competition with human polyclonal antibodies. In addition, a preliminary demonstration of the spatial relationship of the epitopes recognized by these mAbs was performed using a cross-blocking assay with a well-characterized human mAb, 26D1. Interestingly, two mAbs recognizing different epitopes were found to act synergistically in the pseudovirion-based neutralization assay (PBNA). To facilitate cross-lab and cross-study comparison, the international standard (IS) serum 05/134 was used to calibrate the mAbs as well as the human serum samples from the HPV16/18 vaccine recipients. The neutralizing mAbs, particularly those that recognizing immunodominant epitopes, would be useful in developing epitope-specific assays for monitoring the vaccine production process and for serological assessment.
引用
- Zhang C, Huang X, Chen S, et al. Epitope clustering analysis for vaccine-induced human antibodies in relationship to a panel of murine monoclonal antibodies against HPV16 viral capsid. Vaccine. 2018. PMID: 30287156. doi:10.1016/j.vaccine.2018.09.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。